A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
Clinical trial NCT03737812 · COMPLETED
Trial details
- NCT number
- NCT03737812
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2021-01-15
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.